… major bleeding at a rate of 3.52 events/100 patient-years with a similar event rate in each
arm (n = 395 rivaroxaban vs. n = 384 warfarin). The median number of transfused packed red …

… rivaroxaban and warfarin initiators. In the ARISTOTLE trial, apixaban showed a significantly
lower rate of major bleeding compared to warfarin (… incidence rate and risk of major bleeding …

… Interestingly, our study showed similar crude incidence rates of major bleeding among
rivaroxaban and warfarin patients (around 4.6 per 100 person-years) although studies have …

… The rates of major bleeding in this study (2.8%-6% per 100 patient-years), while significantly
higher than the rates in … bleeding rates associated with NOACs and warfarin and assessed …

… rivaroxaban and warfarin. Among patients with and without atrial fibrillation who were
prescribed rivaroxaban, we observed similar rates … 1-year risk of major bleeding in patients with …

… Rivaroxaban and warfarin patients did not differ significantly in baseline … rates for
thromboembolic and major bleeding events. Compared with patients on warfarin, those on …

… Our data indicate that, in real life, rates of rivaroxaban-related major bleeding may be lower
… -cause mortality after major bleeding with rivaroxaban compared with warfarin (hazard ratio …

… -world rate of major bleeding observed in patients receiving either dabigatran or rivaroxaban
… among patients managed on warfarin anticoagulation which would be additively informative…

… study were ischemic stroke and major bleeding events within rivaroxaban and warfarin cohorts.
A … major bleeding was identified using the Cunningham criteria, which identifies bleeding …

… the rivaroxaban group, as did bleeding that led to a drop in the hemoglobin level or bleeding
… were at increased risk for bleeding events, rates of major bleeding were similar to those in …